May 23, 2019
FDA grants Stryker premarket approval for intracranial aneurysm stent
Editor's Note
Stryker announced on May 20 that the Food & Drug Administration (FDA) granted premarket approval for its Neuroform Atlas stent system for intracranial aneurysms, the May 20 MassDevice reports.
The self-expanding nitinol stent can now be used with neurovascular embolization coils to treat patients with saccular wide-necked intracranial aneurysms that arise from a 2 mm to 4.5 mm parent vessel.
Free Daily News
- HHS report highlights cost, access, quality concerns with private equity in healthcare
- Study: Racial, gender disparities persist in bariatric surgery
- Study: Dry eye risks complicate cataract surgery recovery
- Study: Observational learning ineffective in ensuring nursing student infection control compliance
- Students innovate to reduce OR plastic waste
- OR Business Management Conference 2025 features fresh perspectives, new tracks
- Survey: Bariatric surgery’s fertility benefits not widely understood
- Study highlights nurse staffing disparity in hospitals serving black populations
- Joint Commission issues new workplace violence prevention standards
- AI outperforms experts in ovarian cancer ultrasound detection
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement